Stock screenerAll disclosures →
EDGAR →
DGX
Conviction 82HealthcareScan · Thu, Sep 24, 2026Quest Diagnostics Inc (DGX) closed at $236.43 (+1.47%) on Sep 24, 2026. Price is above its 50-day and above its 200-day moving average. RSI(14) 47, RS Rating 83, -4.5% from its 52-week high, +36.0% year to date. Sector: Healthcare · SERVICES-MEDICAL LABORATORIES.
DGX$236.43+1.47%
ResistanceSupportVol 14Insider sellCongress buyCongress sell3
Vol MA14 1.18M
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
WSB mentions · 24h changelatest +0.00%· 1 mentions
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
Price236.43
Change+1.47%
Gap+0.70%
Rel volume1.08×
Avg volume1.12M
Avg $ vol268.47M
SMA 20239.67
SMA 50235.16
SMA 200204.51
Price vs 50+0.54%
Price vs 200+15.61%
MA stackbullish
50/200 cross—
Supertrendup · 231.40
RSI (14)47
MACD hist-1.09
MACD crossbear · 2d
Stoch %K / %D43 / 35
ADX (14)25
+DI / −DI18 / 28
RSI divergenceBearish
MACD divergence—
ATR %2.51%
ADR %2.28%
52w high247.45
52w low173.49
From 52w high-4.45%
Above 52w low+36.28%
New 52w highNo
SqueezeOff
Bollinger width8.42%
%B0.34
Donchian pos42.55%
Donchian high248.84
Donchian low227.24
AVWAP (52w high)235.87
vs AVWAP high+0.24%
AVWAP (52w low)207.73
vs AVWAP low+13.81%
OBV trendDown
Chaikin MF (20)0.10
Today vs 20d1.08×
Avg vol (14d)1.18M
Avg vol (20d)1.12M
Avg $ vol (20d)268.47M
Market cap26.1B
RS Rating83 / 99
RS 3m (vs SPY)+10.15%
RS 6m (vs SPY)+3.53%
RS line new highNo
Trend template8/8
Technical rank71.9
1 week-4.45%
1 month-3.30%
3 months+14.64%
6 months+20.35%
1 year+26.45%
YTD+36.04%
P/E26.31
P/B3.47
P/S2.36
P/FCF19.20
EPS8.75
Div yield1.35%
ROE13.20%
ROA5.86%
Debt/Eq0.75
Current1.59
EV/EBITDA14.63
Gross margin32.92%
Net margin8.99%
Rev growth11.78%
EPS growth13.89%
Price target255.00
Target upside7.85%
Analyst ratingBuy
Institutional108.60%
Ent. value31.11B
Revenue3.04B
Net income320M
Gross profit—
Free cash flow1.36B
IndustrySERVICES-MEDICAL LABORATORIES
ExchangeNYSE
Shares out110.7M
Employees57K
ListedTue, Dec 17, 1996
Free float109.45M
Float %99.6%
Short interest3.45M
Days to cover3.9d
Short volume61.3%
Squeeze score41 / 100
Next earningsThu, Oct 22, 2026 · pre-mkt (28d)
EPS forecast$2.85 · 8 est
Last EPS vs est$3.12 vs $2.81
Last surprise+11.0% beat
Setup gradeA
Conviction82 / 100
Pattern quality—
Tech rank71.9 / 100
Group rank59 / 100
Status lane—
Setup direction—
Pattern family
Resistance247.34
Support228.52
Days since event—
Candle confirm—
Financials as of Tue, Jun 30, 2026 · quarterly.
Signal lifecycle
How this symbol has moved through the lanes across 60 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.
- Broke outJul 241 scan
- Setting upAug 4 – Sep 26 scans
Recent news
- Quest Diagnostics (DGX) Could Be 5% Below Fair Value After Apple Health LaunchYahoo Finance · Wed, Sep 23, 2026
- Quest Diagnostics (DGX) Stock Could Be 30% Below Fair Value Following Medicare Payment Cut ConcernsYahoo Finance · Tue, Sep 22, 2026
- Quest Diagnostics to Release Third Quarter Financial Results on October 22, 2026PR Newswire · Tue, Sep 22, 2026
- Why Quest Diagnostics Holdings Stock Dropped TodayMotley Fool · Tue, Sep 22, 2026
- Quest Diagnostics Study Finds High Tick-Borne Disease Co-ExposureYahoo Finance · Tue, Sep 22, 2026
- Quest Diagnostics, Labcorp Shares Fall as Medicare Signals Cuts in Payment Rates for Lab ServicesYahoo Finance · Tue, Sep 22, 2026
- Is This the Right Time to Add DGX Stock to Your Portfolio?Yahoo Finance · Tue, Sep 22, 2026
- Is Quest Diagnostics Stock Outperforming the Nasdaq?Barchart · Tue, Sep 22, 2026
- Premarket movers: Quest, Labcorp hit by CMS cutsYahoo Finance · Tue, Sep 22, 2026
- Quest Diagnostics Sees Growth Outpace Targets as Consumer Testing SurgesMarketbeat · Mon, Sep 21, 2026
Congress activity
Disclosed STOCK Act trades in DGX · 8 recent
| Member | Side | Amount | Traded | Filed | PTR |
|---|---|---|---|---|---|
 Carol Devine Miller house · R · WV · traded 2025-03-10 | Sell | $15K–$50K | 2025-03-10 | 2026-08-13 | |
 Julie Johnson house · D · TX · traded 2025-10-30 | Sell | $1K–$15K | 2025-10-30 | 2026-08-05 | |
 Alan Armstrong senate · R · OK · traded 2026-03-30 | Buy | $1K–$15K | 2026-03-30 | 2026-07-21 | |
Alan Armstrong senate · R · OK · traded 2026-03-27 | Buy | $1K–$15K | 2026-03-27 | 2026-07-21 | |
RK Rohit Khanna house · CA | Other | — | — | 2026-03-09 | |
 Julia Letlow house · LA · traded 2025-07-24 | Sell | $1K–$15K | 2025-07-24 | 2025-08-11 | |
Carol Devine Miller house · R · WV · traded 2025-03-10 | Sell | $1K–$15K | 2025-03-10 | 2025-04-11 | |
 Thomas H Tuberville senate · traded 2024-01-03 | Sell | $15K–$50K | 2024-01-03 | 2024-02-14 |
Insider activity
SEC Form 4 transactions in DGX · open-market 3 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
PREVOZNIK MICHAEL E SVP & General Counsel · Common Stock · 2026-08-28 | Exercise | 22.68K | $2.5M | 2026-08-28 | 2026-08-31 |
PREVOZNIK MICHAEL E SVP & General Counsel · Common Stock · 2026-08-28 | Sell | 16.01K | $3.9M | 2026-08-28 | 2026-08-31 |
PREVOZNIK MICHAEL E SVP & General Counsel · Common Stock · 2026-08-28 | Sell | 6.24K | $1.5M | 2026-08-28 | 2026-08-31 |
PREVOZNIK MICHAEL E SVP & General Counsel · Common Stock · 2026-08-28 | Sell | 430 | $105K | 2026-08-28 | 2026-08-31 |
PREVOZNIK MICHAEL E SVP & General Counsel · Common Stock · 2026-08-28 | Gift | 1K | — | 2026-08-28 | 2026-08-31 |
PREVOZNIK MICHAEL E SVP & General Counsel · Non-Qualifed Stock Option (right to buy) · 2026-08-28 | Exercise | 22.68K | $2.5M | 2026-08-28 | 2026-08-31 |
Plewman Patrick SVP for Diagnostic Services · Common Stock · 2026-07-22 | Acquire | 46 | $10K | 2026-07-22 | 2026-07-27 |
SAMAD SAM Executive Vice President & CFO · Common Stock · 2026-07-22 | Grant | 102 | $21K | 2026-07-22 | 2026-07-27 |
CARTER ROBERT B Director · Common Stock · 2026-07-22 | Acquire | 11 | $2K | 2026-07-22 | 2026-07-27 |
DELANEY MARK E SVP & Chief Commercial Officer · Common Stock · 2026-07-22 | Acquire | 34 | $7K | 2026-07-22 | 2026-07-27 |
SEC filings
EDGAR filings in DGX · 8 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.